Safety and Efficacy of Nebivolol in the Treatment of Hypertension in African Americans
Clinical trial NCT00145210 · COMPLETED
Trial details
- NCT number
- NCT00145210
- Sponsor
- Mylan Bertek Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-04-01
- Primary completion
- 2007-09-01
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.